Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001707797-26-000003

Options or other derivatives

  • Director acquired 1,339 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jain Rita Director 2026-03-31 Grant or award · Stock Option (Right to Buy) +1,339 $12.13 $16,242 1,339 D: show line 1 in the form
Loading xslF345X06/form4-04012026_040410.xml…